PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)

抗高血压反应的药物遗传学评价（梨）

• 批准号: 7603690
• 负责人: ARLENE B CHAPMAN
• 金额: $ 3.2万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7603690
• 关键词: Adrenergic beta-Antagonists; Antihypertensive Agents; Candidate Disease Gene; Computer Retrieval of Information on Scientific Projects Database; Diuretics; Evaluation; Funding; Genes; Genetic Polymorphism; Grant; Institution; Numbers; Patients; Pharmacogenetics; Purpose; Research; Research Personnel; Resources; Source; Testing; Thiazide Diuretics; United States National Institutes of Health; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine the association of a large number of genes with responses to diuretics and beta-blockers in hypertensive patients. It will test the hypothesis that 1) polymorphisms in proposed candidate genes are important determinants of the inter-patient variance in antihypertensive and adverse response to B-blockers and thiazide diuretics; and 2) there are a substantial number of new genes that are important determinants of the interpatient variance in antihypertensive and adverse responses to B-blockers and thiazide diuretics.

这个子项目是众多研究子项目之一